SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15668754
Source:
http://linkedlifedata.com/resource/pubmed/id/15668754
Search
Subject
(
63
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011777
,
umls-concept:C0013216
,
umls-concept:C0026056
,
umls-concept:C0042963
,
umls-concept:C0061863
,
umls-concept:C0205178
,
umls-concept:C0205250
,
umls-concept:C0205269
,
umls-concept:C0282460
pubmed:issue
6
pubmed:dateCreated
2005-6-9
pubmed:abstractText
To assess whether the addition of midazolam to dexamethasone and granisetron could ameliorate the refractory acute nausea and/or vomiting caused by a highly emetogenic platinum-based chemotherapy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9302957
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone
,
http://linkedlifedata.com/resource/pubmed/chemical/Granisetron
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypnotics and Sedatives
,
http://linkedlifedata.com/resource/pubmed/chemical/Midazolam
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0941-4355
pubmed:author
pubmed-author:Bari?LL
,
pubmed-author:CabidduMM
,
pubmed-author:CazzanigaMM
,
pubmed-author:CremonesiMM
,
pubmed-author:Di CosimoSS
,
pubmed-author:FerrettiGG
,
pubmed-author:GhilardiMM
,
pubmed-author:MandalàMM
,
pubmed-author:RoccaAA
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
375-80
pubmed:meshHeading
pubmed-meshheading:15668754-Adult
,
pubmed-meshheading:15668754-Aged
,
pubmed-meshheading:15668754-Analysis of Variance
,
pubmed-meshheading:15668754-Antineoplastic Agents
,
pubmed-meshheading:15668754-Cisplatin
,
pubmed-meshheading:15668754-Dexamethasone
,
pubmed-meshheading:15668754-Female
,
pubmed-meshheading:15668754-Granisetron
,
pubmed-meshheading:15668754-Humans
,
pubmed-meshheading:15668754-Hypnotics and Sedatives
,
pubmed-meshheading:15668754-Male
,
pubmed-meshheading:15668754-Midazolam
,
pubmed-meshheading:15668754-Middle Aged
,
pubmed-meshheading:15668754-Nausea
,
pubmed-meshheading:15668754-Neoplasms
,
pubmed-meshheading:15668754-Statistics, Nonparametric
,
pubmed-meshheading:15668754-Treatment Outcome
,
pubmed-meshheading:15668754-Vomiting
pubmed:year
2005
pubmed:articleTitle
Midazolam for acute emesis refractory to dexamethasone and granisetron after highly emetogenic chemotherapy: a phase II study.
pubmed:affiliation
Division of Medical Oncology, Treviglio Hospital, P.le Ospedale 1, 24047, Treviglio (BG), Italy. mariomandala@tin.it
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Clinical Trial, Phase II